VisionQuest Biomedical Inc. develops artificial intelligence–based medical devices for the ophthalmic and diabetes-care markets. We began with an idea—to simplify the diagnosis of diabetic retinopathy in ever-increasing numbers of diabetes patients and to bring cutting-edge artificial intelligence technology to everyday eye care. That idea has evolved into a series of software products that empower hospitals, health-care centers, and laboratories in the early detection of diabetic retinopathy, as well as diabetic peripheral neuropathy (diabetic foot), cerebral malaria, and the retinopathy of prematurity. Our products and technology are currently deployed in countries around the world, providing quick, accessible, and contactless testing solutions.